Role of CO-binding cytochrome c in enzymatic oxidation of methane by the bacterium Methylococcus capsulatus

The cytochrome c spectrally related to cco cytochromes has been isolated and purified from the methane-oxidizing bacterium Methylococcus capsulatus. The cytochrome binds CO but does not bind other substrates of methane monooxygenase, does not activate the methane monooxygenase reaction and is not a component of methane monooxygenase. In the methanol dehydrogenase enzymatic system cytochrome cco functions as electron acceptor. A possible role of cytochrome cco as electron carrier intermediate in the sequence of the dehydrogenase and oxidase enzymatic systems of M. capsulatus is discussed.     

Alkyl Chain Engineering of Solution‐Processable Star‐Shaped Molecules for High‐Performance Organic Solar Cells

The impact of alkyl side‐chain substituents on conjugated polymers on the photovoltaic properties of bulk heterojunction (BHJ) solar cells has been studied extensively, but their impact on small molecules has not received adequate attention. To reveal the effect of side chains, a series of star‐shaped molecules based on a triphenylamine (TPA) core, bithiophene, and dicyanovinyl units derivatized with various alkyl end‐capping groups of methyl, ethyl, hexyl and dodecyl is synthesiyed and studied to comprehensively investigate structure‐properties relationships. UV‐vis absorption and cyclic voltammetry data show that variations of alkyl chain length have little influence on the absorption and highest occupied molecular orbital (HOMO)‐lowest unoccupied molecular orbital (LUMO) levels. However, these seemingly negligible changes have a pronounced impact on the morphology of BHJ thin films as well as their charge carrier separation and transportation, which in turn influences the photovoltaic properties of these small‐molecule‐based BHJ devices. Solution‐processed organic solar cells (OSCs) based on the small molecule with the shortest methyl end groups exhibit high short circuit current (J_sc) and fill factor (FF), with an efficiency as high as 4.76% without any post‐treatments; these are among the highest reported for solution‐processed OSCs based on star‐shaped molecules.     

Effects of Alkyl Terminal Chains on Morphology,Charge Generation,Transport, and Recombination Mechanisms in Solution‐Processed Small Molecule Bulk Heterojunction Solar Cells

Length of the terminal alkyl chains at dicyanovinyl (DCV) groups of two dithienosilole (DTS) containing small molecules ( DTS(Oct)₂‐(2T‐DCV‐Me)₂ and DTS(Oct)₂‐(2T‐DCV‐Hex)₂ ) is investigated to evaluate how this affects the molecular solubility and blend morphology as well as their performance in bulk heterojunction organic solar cells (OSCs). While the DTS(Oct)₂‐(2T‐DCV‐Me)₂ (a solubility of 5 mg mL^?1) system exhibits both high short circuit current density (J _sc) and high fill factor, the DTS(Oct)₂‐(2T‐DCV‐Hex)₂ (a solubility of 24 mg mL^?1) system in contrast suffers from a poor blend morphology as examined by atomic force morphology and grazing incidence X‐ray scattering measurements, which limit the photovoltaic properties. The charge generation, transport, and recombination dynamics associated with the limited device performance are investigated for both systems. Nongeminate recombination losses in DTS(Oct)₂‐(2T‐DCV‐Hex)₂ system are demonstrated to be significant by combining space charge limited current analysis and light intensity dependence of current–voltage characteristics in combination with photogenerated charge carrier extraction by linearly increasing voltage and transient photovoltage measurements. DTS(Oct)₂‐(2T‐DCV‐Me)₂ in contrast performs nearly ideal with no evidence of nongeminate recombination, space charge effects, or mobility limitation. These results demonstrate the importance of alkyl chain engineering for solution‐processed OSCs based on small molecules as an essential design tool to overcome transport limitations.     

Study of the Characteristics of the Positive Column of a Direct Current Glow Discharge in Xenon

Plasma Physics Reports - Experimental and theoretical studies of plasma parameters of the positive column of a direct current glow discharge in xenon were carried out. In the experiments, a...     

T Cell Receptor Signaling Co-regulates Multiple Golgi Genes to Enhance N-Glycan Branching

T cell receptor (TCR) signaling enhances β1,6GlcNAc-branching in N-glycans, a phenotype that promotes growth arrest and inhibits autoimmunity by increasing surface retention of cytotoxic T lymphocyte antigen-4 (CTLA-4) via interactions with galectins. N-Acetylglucosaminyltransferase V (MGAT5) mediates β1,6GlcNAc-branching by transferring N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to N-glycan substrates produced by the sequential action of Golgi α1,2-mannosidase I (MIa,b,c), MGAT1, α1,2-mannosidase II (MII, IIx), and MGAT2. Here we report that TCR signaling enhances mRNA levels of MIa,b,c and MII,IIx in parallel with MGAT5, whereas limiting levels of MGAT1 and MGAT2. Blocking the increase in MI or MII enzyme activity induced by TCR signaling with deoxymannojirimycin or swainsonine, respectively, limits β1,6GlcNAc-branching, suggesting that enhanced MI and MII activity are both required for this phenotype. MGAT1 and MGAT2 have an ∼250- and ∼20-fold higher affinity for UDP-GlcNAc than MGAT5, respectively, and increasing MGAT1 expression paradoxically inhibits β1,6GlcNAc branching by limiting UDP-GlcNAc supply to MGAT5, suggesting that restricted changes in MGAT1 and MGAT2 mRNA levels in TCR-stimulated cells serves to enhance availability of UDP-GlcNAc to MGAT5. Together, these data suggest that TCR signaling differentially regulates multiple N-glycan-processing enzymes at the mRNA level to cooperatively promote β1,6GlcNAc branching, and by extension, CTLA-4 surface expression, T cell growth arrest, and self-tolerance.     

Metastasis-Inducing S100A4 and RANTES Cooperate in Promoting Tumor Progression in Mice

Background

The tumor microenvironment has been described as a critical milieu determining tumor growth and metastases. A pivotal role of metastasis-inducing S100A4 in the development of tumor stroma has been proven in animal models and verified in human breast cancer biopsies. Expression and release of S100A4 has been shown in various types of stroma composing cells, including fibroblasts and immune cells. However, the events implicated in upstream and downstream pathways regulating the activity of the extracellular S100A4 protein in the tumor milieu remain unsolved.

Methodology/Principal Findings

We studied the interplay between the tumor cell-derived cytokine regulated-upon-activation, normal T-cell expressed and secreted (RANTES; CCL5) and S100A4 which were shown to be critical factors in tumor progression. We found that RANTES stimulates the externalization of S100A4 via microparticle shedding from the plasma membrane of tumor and stroma cells. Conversely, the released S100A4 protein induces the upregulation of fibronectin (FN) in fibroblasts and a number of cytokines, including RANTES in tumor cells as well as stimulates cell motility in a wound healing assay. Importantly, using wild type and S100A4-deficient mouse models, we demonstrated a substantial influence of tumor cell-derived RANTES on S100A4 release into blood circulation which ultimately increases the metastatic burden in mice.

Conclusions/Significance

Altogether, the data presented strongly validate the pro-metastatic function of S100A4 in the tumor microenvironment and define how the tumor cell-derived cytokine RANTES acts as a critical regulator of S100A4-dependent tumor cell dissemination. Additionally, for the first time we demonstrated the mechanism of S100A4 release associated with plasma membrane microparticle shedding from various cells types.     

A study of the localization and accumulation of S-phase cells in the retina of newt Pleurodeles waltl after experimental pigment epithelial detachment

This work continues the studies of the proliferative ability of cells in the adult newt retina. The model of experimental detachment of the retina from pigment epithelium and two techniques to saturate the ocular tissues in vivo with precursors of DNA synthesis were used: (1) the method of repeated [3H]-thymidine labeling and subsequent autoradiographic analysis of semithin sections and (2) an original method for continuous labeling of thymidine analog bromodeoxyuridine and subsequent immunochemical detection. The data obtained confirm and extend our previous data on the localization of DNA-synthesizing cells in the neural retina and expose the pattern of S-phase cell accumulation after retinal detachment for each proliferation-competent cell population. In addition to cells in the growth zone of the retina, Muller glia, microglia, and minor cell population in the vitreal part of interneurons, DNA-synthesizing cells included astrocytes of the optic nerve and cells of its vascular network. Four weeks after detachment, the number of S-phase cells in the growth zone could reach 15-20%, while the above-mentioned DNA-synthesizing cells in the differentiated retina have low reproductive rate and could produce only one generation within the same period.